Johnson & Johnson (JNJ)
158.19
-0.13
(-0.08%)
USD |
NYSE |
Jun 06, 16:00
158.20
+0.01
(+0.01%)
After-Hours: 19:01
Johnson & Johnson Research and Development Expense (Annual): 15.39B for Dec. 31, 2022
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 15.39B |
| December 31, 2021 | 15.61B |
| December 31, 2020 | 12.34B |
| December 31, 2019 | 11.36B |
| December 31, 2018 | 10.78B |
| December 31, 2017 | 10.59B |
| December 31, 2016 | 9.143B |
| December 31, 2015 | 9.046B |
| December 31, 2014 | 8.494B |
| December 31, 2013 | 8.183B |
| December 31, 2012 | 7.665B |
| December 31, 2011 | 7.548B |
| December 31, 2010 | 6.844B |
| December 31, 2009 | 6.986B |
| December 31, 2008 | 7.577B |
| Date | Value |
|---|---|
| December 31, 2007 | 7.68B |
| December 31, 2006 | 7.125B |
| December 31, 2005 | 6.462B |
| December 31, 2004 | 5.344B |
| December 31, 2003 | 4.684B |
| December 31, 2002 | 3.957B |
| December 31, 2001 | 3.591B |
| December 31, 2000 | 3.105B |
| December 31, 1999 | 2.768B |
| December 31, 1998 | 2.336B |
| December 31, 1997 | 2.14B |
| December 31, 1996 | |
| December 31, 1995 | |
| December 31, 1994 | 1.278B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
10.78B
Minimum
2018
15.61B
Maximum
2021
13.09B
Average
12.34B
Median
2020
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.434B |
| Gilead Sciences Inc | 4.977B |
| Eli Lilly and Co | 7.191B |
| Merck & Co Inc | 13.55B |
| Moderna Inc | 3.295B |